Hans Lennart Rudolf Wigzell

Insider Reports History

Location
Hagersten, Sweden
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Hans Wigzell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans Lennart Rudolf Wigzell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 25,223 $2,525,579 $100.13 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Options (right to buy) 4,792 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Option (right to buy) 0 08 Mar 2024 Direct

Insider Reports Filed by Hans Lennart Rudolf Wigzell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 10 Mar 2025 2 $0 4 Director 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 12 Dec 2024 3 -$1,166,865 4 Director 16 Dec 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 08 Mar 2024 5 -$1,640,295 4 Director 11 Mar 2024, 20:02
SRPT Sarepta Therapeutics, Inc. 01 Mar 2024 2 $0 4 Director 05 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Aug 2023 3 -$1,165,350 4 Director 08 Aug 2023, 20:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2023 2 $0 4 Director 08 Mar 2023, 19:01
SRPT Sarepta Therapeutics, Inc. 07 Mar 2022 2 $0 4 Director 08 Mar 2022, 19:05